Medication-induced weight gain and dyslipidemia in patients with schizophrenia.
Fenton
Wayne S
WS
Division of Adult Trasnlation Reserach and Treatment Development, NIMH, Bethesda, MD, USA.
Chavez
Mark R
MR
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015897:Comorbidity; D050171:Dyslipidemias / Q000097:blood / Q000139:chemically induced*; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000139:chemically induced / Q000175:diagnosis / Q000453:epidemiology; D009765:Obesity / Q000097:blood / Q000139:chemically induced; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D015430:Weight Gain / Q000187:drug effects*
D014150:Antipsychotic Agents